
    
      Patients diagnosed ventilator-associated tracheobronchitis due to gram negative organism are
      included to the study.The patients will be received colistin inhalation 75 mg every 12 hours
      at least 5 days.

      The primary objective is to evaluate clinical outcome of inhaled colistin. The secondary
      objectives are microbiological clearance and toxicity of inhaled colistin.

      The sample size was estimated to 62 patients.
    
  